Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
about
Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesisFetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and managementA new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiencyMedium-chain acyl-CoA dehydrogenase deficiency in gene-targeted miceA general introduction to the biochemistry of mitochondrial fatty acid β-oxidationMitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studiesMitochondrial long chain fatty acid beta-oxidation in man and mouseMitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistanceCardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiencySIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationCarnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout miceMitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidationLong-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunctionCarnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) MiceHuman acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids.Dynamic simulations on the mitochondrial fatty acid beta-oxidation network.Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE.Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse modelsMouse models for disorders of mitochondrial fatty acid beta-oxidation.Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia.Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient miceDietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta.Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.Mitochondrial beta-oxidation.Acadl-SNP based genotyping assay for long-chain acyl-CoA dehydrogenase deficient miceAortic wall proteomic analysis in spontaneously hypertensive rats with a blood pressure decrease induced by 6-week load-free swimming.Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndromeAnaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years ExperienceHomozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouseGenetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autismSensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expressionMetabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseasesHepatic triacylglycerol accumulation and insulin resistance.Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weightLow expression of long-chain acyl-CoA dehydrogenase in human skeletal muscleFatty acid oxidation and meiotic resumption in mouse oocytesVery long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.Biochemical correction of very long-chain acyl-CoA dehydrogenase deficiency following adeno-associated virus gene therapy.
P2860
Q21563343-99E3A3E2-3293-4E07-9988-49D325F1E795Q24616340-2A84EC1C-6B49-4774-817A-981E0FD4BA5DQ24676560-6F0055FB-5F23-4D7D-A611-11654274796DQ24814997-D0694A25-FCEB-4BD5-B67E-1F9FC8F3DE32Q26699142-C69C2126-8DF6-482A-9958-7518C1F28DDAQ28085600-23C25B17-3A37-442D-8B84-F50934693647Q28246062-16347B64-3DD6-49B0-BD52-2019121BF96CQ28253498-3F70AB10-9C10-4240-83B3-1290DA8E0076Q28257772-E00AB982-BED9-467A-B66E-7B5942050C41Q28275010-4D38B3C3-E114-4E1C-A0D2-2B8848C44B1CQ28288565-226A1B72-327D-4386-8E0A-C2B05F3CFCA1Q28307555-2A72A76A-A1AE-42F4-93F0-A028594DA734Q28308215-7AA3F26E-9B1E-4609-BA95-A17BFF7B40EFQ28507159-FA978FBA-9842-4EFD-AB6B-8A3950A55A1CQ33219567-65B4B8EB-37E9-4AB7-B67C-7172DDFAE044Q33397846-DE56578B-028D-44EE-A45E-DD4BD8F33D08Q33617698-4C51BBB0-0B04-4308-8A37-3086ADCFD91AQ34002504-030EC70D-E3A5-4ABC-B14B-E6EA998DCF42Q34163820-78A5FE54-0026-4121-BFDA-05CF55CFE521Q34578754-2EA45B88-3012-489F-B5D6-86D31027C9D9Q35023635-9AF2A7A7-FDF5-43B5-A52E-14239FAA6CD0Q35055915-6AE7630D-9E85-4F97-9620-7F3AC6C3BF97Q35159373-0DDB4E60-6C73-4A66-BA9F-106161618084Q35315061-30DBE6C3-5E40-405F-8BEF-3FC1824C462CQ35631612-341FD269-72B4-4D8D-9CD2-B2971FBDFBDEQ35911338-0986A88E-0C66-4CC7-BA5E-59F7465005E1Q35948057-3346775C-C77D-4CF8-9EA8-7C4A06B66CCBQ36084447-4ACBF711-A70B-4ECA-8B54-22C138466B5BQ36461753-B07DAB02-9614-4FDB-B43F-45C92D89809AQ36501934-13086302-979E-4E68-A17E-6B73A81D961AQ36718178-CE6B98EE-AD61-4341-8CAD-722649A887A9Q37204659-99E8EF52-64B4-4099-9AD5-91FBAD214DE3Q37236343-336F7E23-50BB-47D3-A20C-C267671B2ACCQ37287373-3503E80A-873A-477A-9098-598BFF2983A9Q37321860-742052D3-A0B7-433E-87B2-760F575AC3FBQ37465084-CCC0E52D-DA50-4BC2-9425-ED2E102FA34CQ37682615-3E6A2BA9-1486-4156-A7EE-3D4A2C1F7103Q37716335-A405812F-4FAB-4839-B035-F18B48DBB0B7Q39155672-EB27087C-DD9B-4E45-A082-0148C983CB93Q39504973-A75D3FF9-6AC1-4BE8-8AAE-4B42176E7405
P2860
Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@en
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@nl
type
label
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@en
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@nl
prefLabel
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@en
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@nl
P2093
P356
P1476
Gestational, pathologic and bi ...... enase deficiency in the mouse.
@en
P2093
Lindsey JR
Millington DS
Pinkert CA
P304
P356
10.1093/HMG/10.19.2069
P577
2001-09-01T00:00:00Z